• Theralase Technologies Inc.

News Releases

Theralase PDT Technology Used to Treat Third Patient for Bladder CancerThursday, April 20, 2017 - 10:00 AM EDT
Theralase PDT Technology Used to Treat Second Patient for Bladder CancerTuesday, April 18, 2017 - 11:00 AM EDT
Theralase Grants Stock OptionsTuesday, April 18, 2017 - 9:00 AM EDT
Theralase Affiliated Researchers to Present at International ConferenceWednesday, April 12, 2017 - 11:00 AM EDT
Theralase Announces Acceptance of Peer Reviewed Publication for Next Generation Anti-Cancer DrugsThursday, April 06, 2017 - 11:00 AM EDT
Theralase PDT Technology Used to Treat First Patient for Bladder CancerTuesday, April 04, 2017 - 7:00 AM EDT
Theralase Demonstrates 18 Month Stability of Lead Anti-Cancer DrugWednesday, March 15, 2017 - 7:00 AM EDT
Theralase Releases AGM Presentation VideoWednesday, December 14, 2016 - 7:00 AM EST
Theralase Adopts Advance Notice By-LawTuesday, December 13, 2016 - 7:00 AM EST
Theralase Commences Phase Ib Clinical StudyFriday, December 09, 2016 - 7:00 AM EST

Pages


  • Company Website, Regulatory Filings and Social Media Links

    To view the regulatory filings for Theralase Technologies Inc., or to follow Theralase Technologies Inc. on your favorite social media platform, please click on the icons below.


Detailed Stock Chart and Company Information